Pfizer and BioNTech receive Emergency Use Authorization for COVID-19 vaccine in adolescents
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
Scientific, technological and communications excellence has been celebrated at the Virtual Cancer and Immunology Research Summit, with Logos Biosystems, INTEGRA Biosciences and Sartorius among those recognized
UN3373 compliant sample packaging solution
Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery
Explore topics from HRIM-MS for enhancing structural characterization to microbial monitoring, in situ hybridization and advances in fragrance profiling
Sartorius_Komal_Javarappa_March2021.txt
Discover how to increase precision and reduce throughput time of your routine electrolyte analyses
Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery
The findings could lead to faster, more secure memory storage, in the form of antiferromagnetic bits